6 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 35453287 | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341. | 2022 Mar 30 | 1 | ||
2 | 32427286 | Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales. | 2021 Jun 1 | 1 | ||
3 | 33276387 | Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. | 2021 Feb 11 | 2 | ||
4 | 33367916 | Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales. | 2021 Mar 12 | 2 | ||
5 | 29336873 | Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228. | 2018 Feb 15 | 1 | ||
6 | 26498989 | A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. | 2015 Nov | 2 |